Levonorgestrel in Preventing Ovarian Cancer in Patients at High Risk for Ovarian Cancer

NCT00445887 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

60

Enrollment

NETWORK

Sponsor class

Conditions

Ovarian Carcinoma

Interventions

OTHER: Laboratory Biomarker Analysis
DRUG: Levonorgestrel
OTHER: Placebo

Sponsor

Gynecologic Oncology Group

Collaborators

[object Object]